Suppr超能文献

利用自由基-腺苷-L-甲硫氨酸核糖体合成和翻译后修饰肽成熟酶的底物通用性用于分子内肽交联应用。

Leveraging Substrate Promiscuity of a Radical -Adenosyl-L-methionine RiPP Maturase toward Intramolecular Peptide Cross-Linking Applications.

作者信息

Eastman Karsten A S, Kincannon William M, Bandarian Vahe

机构信息

Department of Chemistry, University of Utah, 315 South 1400 East, Salt Lake City, Utah 84112, United States.

出版信息

ACS Cent Sci. 2022 Aug 24;8(8):1209-1217. doi: 10.1021/acscentsci.2c00501. Epub 2022 Aug 1.

Abstract

Radical -adenosyl-l-methionine (RS) enzymes operate on a variety of substrates and catalyze a wide range of complex radical-mediated transformations. Radical non-α-carbon thioether peptides (ranthipeptides) are a class of ribosomally synthesized and post-translationally modified peptides (RiPPs). The RS enzyme PapB catalyzes the formation of thioether cross-links between Cys/Asp (or Cys/Glu) residues located in six Cys-X-Asp/Glu motifs. In this report, using a minimal substrate that contains a single cross-link motif, we explore the substrate scope of the PapB and show that the enzyme is highly promiscuous and will accept a variety of Cys-X -Asp sequences where = 0-6. Moreover, we show that the enzyme will introduce in-line and nested thioether cross-links independently in peptide sequences that contain two motifs derived from the wild-type sequence. Additionally, the enzyme accepts peptides that contain d-amino acids at either the Cys or the Asp position. These observations are leveraged to produce a thioether cyclized analogue of the FDA-approved therapeutic agent octreotide, with a Cys-Glu cross-link replacing the disulfide that is found in the drug. These findings highlight the remarkable substrate tolerance of PapB and show the utility of RS RiPP maturases in biotechnological applications.

摘要

自由基 - 腺苷甲硫氨酸(RS)酶作用于多种底物,催化一系列复杂的自由基介导的转化反应。自由基非α-碳硫醚肽(ranthipeptides)是一类核糖体合成并经翻译后修饰的肽(RiPPs)。RS酶PapB催化位于六个Cys-X-Asp/Glu基序中的Cys/Asp(或Cys/Glu)残基之间硫醚交联的形成。在本报告中,我们使用包含单个交联基序的最小底物,探索了PapB的底物范围,结果表明该酶具有高度的混杂性,能够接受多种Cys-X -Asp序列,其中 = 0 - 6。此外,我们还表明该酶能够在含有两个源自野生型序列基序的肽序列中独立引入同向和嵌套硫醚交联。另外,该酶还能接受在Cys或Asp位置含有d-氨基酸的肽。利用这些观察结果,我们制备了FDA批准的治疗药物奥曲肽的硫醚环化类似物,用Cys-Glu交联取代了药物中存在的二硫键。这些发现突出了PapB显著的底物耐受性,并展示了RS RiPP成熟酶在生物技术应用中的实用性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21e7/9413430/89a2093541a8/oc2c00501_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验